These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 21596088

  • 21. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
    Vellozzi C, Burwen DR, Dobardzic A, Ball R, Walton K, Haber P.
    Vaccine; 2009 Mar 26; 27(15):2114-20. PubMed ID: 19356614
    [Abstract] [Full Text] [Related]

  • 22. Serious adverse reactions should be further monitored after influenza A (H1N1) vaccination among children: postmarketing experience with 570,000 vaccinations between October 2009 and August 2010 in Guangzhou, China.
    Fu C, Xu J, Tan H, Wang M.
    Pediatr Infect Dis J; 2011 Jul 26; 30(7):631-2. PubMed ID: 21673552
    [No Abstract] [Full Text] [Related]

  • 23. Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district.
    Cristiani C, Tuccori M, Pepe P, Sarteschi A, Maddalo F, Simonini G, Michi P, Consigli V, Fornai M, Antonioli L, Blandizzi C.
    Vaccine; 2011 Apr 18; 29(18):3443-8. PubMed ID: 21396903
    [Abstract] [Full Text] [Related]

  • 24. Immunogenicity and safety of a monovalent vaccine for the 2009 pandemic influenza virus A (H1N1) in children and adolescents.
    Lu CY, Shao PL, Chang LY, Huang YC, Chiu CH, Hsieh YC, Lin TY, Huang LM.
    Vaccine; 2010 Aug 16; 28(36):5864-70. PubMed ID: 20600484
    [Abstract] [Full Text] [Related]

  • 25. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
    Pebody R, Andrews N, Waight P, Malkani R, McCartney C, Ellis J, Miller E.
    Vaccine; 2011 Mar 21; 29(14):2613-8. PubMed ID: 21292008
    [Abstract] [Full Text] [Related]

  • 26. [Pandemic vaccines].
    Floret D.
    Arch Pediatr; 2010 Jun 21; 17(6):906-7. PubMed ID: 20654954
    [No Abstract] [Full Text] [Related]

  • 27. Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination.
    Parretta E, Ianniello B, Ferrazin F, Rossi F, Capuano A.
    Vaccine; 2011 May 09; 29(20):3708-13. PubMed ID: 21406267
    [Abstract] [Full Text] [Related]

  • 28. Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase.
    Torun SD, Torun F.
    Vaccine; 2010 Aug 09; 28(35):5703-10. PubMed ID: 20600497
    [Abstract] [Full Text] [Related]

  • 29. The Vaccine Safety Datalink project.
    DeStefano F, Vaccine Safety Datalink Research Group.
    Pharmacoepidemiol Drug Saf; 2001 Aug 09; 10(5):403-6. PubMed ID: 11802585
    [Abstract] [Full Text] [Related]

  • 30. Monitoring the safety of pandemic H1N1 vaccine.
    Huang WT, Chuang JH, Kuo SH.
    Lancet; 2010 Apr 03; 375(9721):1164. PubMed ID: 20362814
    [No Abstract] [Full Text] [Related]

  • 31. Effectiveness of an adjuvanted monovalent vaccine against the 2009 pandemic strain of influenza A(H1N1)v, in Stockholm County, Sweden.
    Ortqvist A, Berggren I, Insulander M, de Jong B, Svenungsson B.
    Clin Infect Dis; 2011 May 03; 52(10):1203-11. PubMed ID: 21507917
    [Abstract] [Full Text] [Related]

  • 32. Intent to receive influenza A (H1N1) 2009 monovalent and seasonal influenza vaccines - two counties, North Carolina, August 2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Dec 25; 58(50):1401-5. PubMed ID: 20032923
    [Abstract] [Full Text] [Related]

  • 33. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP.
    Pediatr Infect Dis J; 2008 Oct 25; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [Abstract] [Full Text] [Related]

  • 34. The safety of the H1N1 influenza A vaccine in egg allergic individuals.
    Greenhawt MJ, Chernin AS, Howe L, Li JT, Sanders G.
    Ann Allergy Asthma Immunol; 2010 Nov 25; 105(5):387-93. PubMed ID: 21055666
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.
    Esposito S, Tagliaferri L, Daleno C, Valzano A, Picciolli I, Tel F, Prunotto G, Serra D, Galeone C, Plebani A, Principi N.
    Vaccine; 2011 Feb 11; 29(8):1677-82. PubMed ID: 21199699
    [Abstract] [Full Text] [Related]

  • 37. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign.
    Bone A, Guthmann JP, Nicolau J, Lévy-Bruhl D.
    Vaccine; 2010 Nov 29; 28(51):8157-61. PubMed ID: 20937310
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Influenza vaccination coverage among children aged 6 months--18 years - eight immunization information system sentinel sites, United States, 2008-09 influenza season.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Oct 02; 58(38):1059-62. PubMed ID: 19798018
    [Abstract] [Full Text] [Related]

  • 40. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Oct 09; 58(39):1100-1. PubMed ID: 19816398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.